Expert Interview
Discussing the recent FDA approval and potential of Takeda's FRUZAQLA (fruquintinib) in previously treated metastatic colorectal cancer patients
Ticker(s): TAKInstitution: Primary Care Associates of Hollister
- Primary Care physician in private practice in California.
- Has prescribed Cologuard to more than 200 patients.
- Practice focuses on diabetes, hypertension, routine office visits, annual examinations including age appropriate screenings, and conducting preoperative clearance.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
